Patients that have gain‐of‐function mutations in NLRP3 develop systemic auto‐inflammatory syndromes called cryopyrin‐associated periodic syndromes (CAPS; Finetti, Omenetti, Federici, Caorsi, & Gattorno, 2016). Here, NLRP3 is linked to cryopyrin-associated periodic syndrome.